Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • PHD
  • Trends in the Global Burden of Glomerulonephritis

    Clinical Journal of the American Society of Nephrology Date published:
  • Challenges and opportunities in interventions for chronic kidney disease of unknown origin (CKDu): report from the International Society of Nephrology Consortium of Collaborators on CKDu

    Kidney International Date published:
  • Our shared responsibility: the urgent necessity of global environmentally sustainable kidney care

    Kidney International Date published:
  • Infectious Complications and Vaccination in Chronic Kidney Disease

    Management of Chronic Kidney Disease Date published:
  • Renal revolution: Anticipating the next 25 years of India's kidney care

    Indian Journal of Nephrology Date published:
  • Indian TrANslational GlomerulonephrItis BioLogy nEtwork (I-TANGIBLE): Design and Methods

    Indian Journal of Nephrology Date published:
  • Effect of Vitamin D Supplementation on Serum Hepcidin Levels in Non-Diabetic Chronic Kidney Disease Patients

    Indian Journal of Nephrology Date published:
  • Diabetes and CKD

    Management of Kidney Diseases Date published:
  • Investigating Kidney Disease

    Management of Kidney Diseases Date published:
  • The Approach to the Patient with Kidney Disease

    Management of Kidney Diseases Date published:
  • Management of Kidney Diseases

    Management of Kidney Diseases Date published:
  • Acute Kidney Injury in the Tropics

    pan class="rg-author">Burdmann EA; Jha V; Srisawat N, 2023, 'Acute Kidney Injury in the Tropics', in Comprehensive Clinical Nephrology Date published:
  • Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease-findings from the ICKD study

    Frontiers in Medicine Date published:
  • ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial

    Trials Date published:
  • Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19

    NEJM Evidence Date published:
  • Heterogeneity of treatment effect of higher dose dexamethasone by geographic region in patients with COVID-19 and severe hypoxemia - Apost hocevaluation of the COVID STEROID 2 trial

    Unknown Date published: